Blackstone Inc’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Blackstone Inc’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,548	Closed	-$311K	–	487
2025 Q4	$311K	Hold	2,548	–	–	﹤0.01%	238
2025 Q3	$255K	Hold	2,548	–	–	﹤0.01%	238
2025 Q2	$211K	Sell	2,548 -234,212	-99%	-$18.7M	﹤0.01%	161
2025 Q1	$19.2M	Buy	236,760 +24,920	+12%	+$2.23M	0.08%	63
2024 Q4	$19.1M	Buy	211,840 +109,810	+108%	+$10.6M	0.09%	63
2024 Q3	$10.1M	Hold	102,030	–	–	0.04%	76
2024 Q2	$9.46M	Hold	102,030	–	–	0.04%	76
2024 Q1	$9.68M	Sell	102,030 -235,000	-70%	-$21.8M	0.04%	83
2023 Q4	$30.1M	Buy	337,030 +293,530	+675%	+$21.8M	0.14%	53
2023 Q3	$3.18M	Hold	43,500	–	–	0.01%	100
2023 Q2	$3.62M	Sell	43,500 -400,000	-90%	-$33.5M	0.02%	99
2023 Q1	$33.8M	Buy	443,500 +50,000	+13%	+$4.15M	0.14%	47
2022 Q4	$32.7M	Buy	393,500 +350,000	+805%	+$28.3M	0.12%	47
2022 Q3	$3.45M	Sell	43,500 -289,240	-87%	-$24.4M	0.01%	90
2022 Q2	$24.7M	Hold	332,740	–	–	0.08%	58
2022 Q1	$29.9M	Buy	+332,740	New	+$30.7M	0.08%	70

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Blackstone Inc's XBI Position: Q1 2026 in Review

Blackstone Inc sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 2,548 shares — an estimated $311K sold.

Blackstone Inc first reported a position in XBI in Q1 2022 and held it in 16 quarters. The position peaked at $33.8M in Q1 2023. 816 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Blackstone Inc reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
Blackstone Inc sold 2,548 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $311K.
Blackstone Inc first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and held it in 16 quarters.
Blackstone Inc's State Street SPDR S&P Biotech ETF position peaked at $33.8M in Q1 2023.
816 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Blackstone Inc's 13F filing for Q1 2026, filed 15 May 2026.